10-73426221-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001024593.2(MSS51):c.659G>A(p.Arg220Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,613,950 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001024593.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSS51 | ENST00000299432.7 | c.659G>A | p.Arg220Gln | missense_variant | 5/7 | 1 | NM_001024593.2 | ENSP00000299432.2 | ||
MSS51 | ENST00000372912.1 | c.659G>A | p.Arg220Gln | missense_variant | 4/6 | 1 | ENSP00000362003.1 | |||
MSS51 | ENST00000487126.5 | n.503-275G>A | intron_variant | 2 | ENSP00000435203.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251116Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135704
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461728Hom.: 1 Cov.: 32 AF XY: 0.0000550 AC XY: 40AN XY: 727152
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 20, 2023 | The c.659G>A (p.R220Q) alteration is located in exon 5 (coding exon 4) of the MSS51 gene. This alteration results from a G to A substitution at nucleotide position 659, causing the arginine (R) at amino acid position 220 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at